BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18843003)

  • 21. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence.
    Martínez ME; Henning SM; Alberts DS
    Am J Clin Nutr; 2004 Apr; 79(4):691-7. PubMed ID: 15051616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
    Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
    J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States).
    Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Hebert JR; Coker A; Wargovich M
    Cancer Causes Control; 2004 Jun; 15(5):493-501. PubMed ID: 15286469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.
    Figueiredo JC; Mott LA; Giovannucci E; Wu K; Cole B; Grainge MJ; Logan RF; Baron JA
    Int J Cancer; 2011 Jul; 129(1):192-203. PubMed ID: 21170989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial.
    Reid ME; Duffield-Lillico AJ; Sunga A; Fakih M; Alberts DS; Marshall JR
    Int J Cancer; 2006 Apr; 118(7):1777-81. PubMed ID: 16217756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
    J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer.
    Stevens VL; McCullough ML; Sun J; Jacobs EJ; Campbell PT; Gapstur SM
    Gastroenterology; 2011 Jul; 141(1):98-105, 105.e1. PubMed ID: 21586288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
    Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States.
    Gibson TM; Weinstein SJ; Pfeiffer RM; Hollenbeck AR; Subar AF; Schatzkin A; Mayne ST; Stolzenberg-Solomon R
    Am J Clin Nutr; 2011 Oct; 94(4):1053-62. PubMed ID: 21813806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas.
    van den Donk M; van Engeland M; Pellis L; Witteman BJ; Kok FJ; Keijer J; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):327-33. PubMed ID: 17301267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence.
    Hubner RA; Muir KR; Liu JF; Logan RF; Grainge MJ; Houlston RS;
    Int J Cancer; 2008 Aug; 123(3):586-93. PubMed ID: 18470879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study).
    Powers HJ; Hill MH; Welfare M; Spiers A; Bal W; Russell J; Duckworth Y; Gibney E; Williams EA; Mathers JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2128-35. PubMed ID: 17932361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
    Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
    Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate intake and risk of colorectal cancer and adenoma: modification by time.
    Lee JE; Willett WC; Fuchs CS; Smith-Warner SA; Wu K; Ma J; Giovannucci E
    Am J Clin Nutr; 2011 Apr; 93(4):817-25. PubMed ID: 21270374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China.
    Ding H; Gao QY; Chen HM; Fang JY
    J Int Med Res; 2016 Aug; 44(4):767-78. PubMed ID: 27358263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.